EPH BioTech Is Warned For Detoxoplex, Sinoplex, Migrenza Supplements

The U.S. Food and Drug Administration, or FDA, has made public its warning letter to Tammie Saunders and her company, EPH Technologies. The agency recently warned Saunders about non-allowed drug claims made about Saunders' Detoxoplex, Sinoplex and Migrenza products.

EPH BioTech is warned for Sinoplex.
Screenshot of archived EPHBioTech.com showing FDA-warned claims about migraine, hangover and more.


Sinoplex

The Sinoplex product was warned for claims that it "may assist" with:
  • Allergy
  • Colds
  • Congestion
  • Dizziness
  • Hangover
  • Headache
  • Migraine
  • Nausea

Detoxoplex

The Detoxolex product is a liquid "supplement" hawked for "withdrawal from opioid use".

Migrenza

Migrenza was warned for its promises involving use for:
  • Congestion
  • Hangover
  • Headache
  • Migraine
Of course none of the products is formally recognized as safe or effective for any of those conditions and are considered "new drugs" by the FDA. 

Tammie Saunders was given the normal 15 working days to respond to the FDA's warning letter, which is dated November 18, 2019. As of my last check, the allegedly illegal claims have been removed from EPH's website but, as you can clearly see from this screenshot, are still being used to peddle products online:
Sinoplex is sold with FDA-warned claims.
Screengrab taken December 16, 2019 by Lisa Barger.
###

Comments